Use of prostaglandin F.sub.3.alpha. as an ocular hypotensive age

Details Use of prostaglandin F.sub.3.alpha. as an ocular hypotensive age Use of prostaglandin F.sub.3.alpha. as an ocular hypotensive age

1991-04-12

1993-03-16

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

514530, 514912, 514913, A61K 3119, A61K 31215

Patent

active

051944499

ABSTRACT:
The invention relates to a means of reducing or maintaining intraocular pressure, and, more particularly, to a method and composition for reducing or maintaining intraocular pressure involving the administration of a composition containing prostaglandin F.sub.3.alpha. in a pharmaceutically acceptable carrier.

REFERENCES:
patent: 4883819 (1989-11-01), Bito

Affiliated with

Also associated with

Rating

Use of prostaglandin F.sub.3.alpha. as an ocular hypotensive age does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of prostaglandin F.sub.3.alpha. as an ocular hypotensive age, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of prostaglandin F.sub.3.alpha. as an ocular hypotensive age will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-350768